Volume 19, Issue 6, June 2019, Page 19-21.

Volume 19, Issue 5, May 2019, Page 68-69.

Innovative practice occurs when a clinician provides something new, untested, or nonstandard to a patient in the course of clinical care, rather than as part of a research study. Commentators have noted that patients engaged in innovative practice are at significant risk of suffering harm, exploitation, or autonomy violations. By creating a pathway for harmful or nonbeneficial interventions to spread within medical practice without being subjected to rigorous scientific evaluation, innovative practice poses similar risks to the wider community of patients (...) and society as a whole. Given these concerns, how should we control and oversee innovative practice, and in particular, how should we coordinate innovative practice and clinical research? In this article, I argue that an ethical approach to overseeing innovative practice must encourage the early transition to rigorous clinical research without delaying or deferring the development of beneficial innovations or violating the autonomy rights of clinicians and their patients. (shrink)

Volume 19, Issue 6, June 2019, Page 42-44.

Volume 19, Issue 6, June 2019, Page 32-34.

Volume 19, Issue 6, June 2019, Page 25-27.

Volume 19, Issue 6, June 2019, Page 34-36.